EDP Sciences logo
Search
Menu
All issues Volume 32 / No 3-4 (May-August 2001) Vet. Res., 32 3-4 (2001) 275-284 References
Free Access
Issue
Vet. Res.
Volume 32, Number 3-4, May-August 2001
Mechanisms of resistance to antibiotics in animal and zoonotic pathogens
Page(s) 275 - 284
DOI https://doi.org/10.1051/vetres:2001124
How to cite this article Vet. Res. (2001) 275-284
  1. Amara A., Ziani Z., Bouzoubaa K., Antibioresistance of Escherichia coli strains isolated in Morocco from chickens with colibacillosis, Vet. Microbiol. 43 (1995) 325-330 [CrossRef] [PubMed].
  2. Anonymous, DANMAP. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark, 1999, ISSN 1600-2032.
  3. Anonymous, WHO. Report of the WHO meeting on the use of quinolones in food animals and potential impact on human health, WHO, Geneva, Switzerland, 1998.
  4. Barbosa T.M., Levy S.B., Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA, J. Bacteriol. 182 (2000) 3467-3474 [CrossRef] [PubMed].
  5. Bazile-Pham-Khac S., Truong Q.C., Lafont J.-P., Guttman L., Zhou X.Y., Osman M., Moreau N.J., Resistance to fluoroquinolones in Escherichia coli isolated from poultry, Antimicrob. Agents Chemother. 40 (1996) 1504-1507 [PubMed].
  6. Blanco J.E., Blanco M., Mora A., Blanco J., Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain, J. Clin. Microbiol. 35 (1997) 2184-2185 [PubMed].
  7. Bradford P.A., Petersen P.J., Fingerman I.M., White D.G., Characterization of expanded-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease, J. Antimicrob. Chemother. 44 (1999) 607-610 [CrossRef] [PubMed].
  8. Breines D.M., Ouabdesselam S., Ng E.Y., Tankovic J., Shah S., Soussy C.J., Hooper D.C., Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV, Antimicrob. Agents Chemother. 41 (1997) 175-179 [PubMed].
  9. Cohen S.P., McMurry L.M., Levy S.B., marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli, J. Bacteriol. 170 (1988) 5416-5422 [PubMed].
  10. Everett M.J., Jin Y.F., Ricci V., Piddock L.J.V., Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals, Antimicrob. Agents Chemother. 40 (1996) 2380-2386 [PubMed].
  11. Fralick J.A., Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli, J. Bacteriol. 178 (1996) 5803-5805 [PubMed].
  12. Garau J., Xercavins M., Rodriguez-Carballeira M., Ramon Gomez-Vera J.R., Coll I., Vidal D., Llovet T., Ruiz-Bremon A., Emergence and dissemination of quinolone-resistant Escherichia coli in the community, Antimicrob. Agents Chemother. 43 (1999) 2736-2741 [PubMed].
  13. Gellert M., Mizuuchi K., O'Dea M.H., Nash H.A., DNA gyrase: an enzyme that introduces superhelical turns into DNA, Proc. Natl. Acad. Sci. USA 73 (1976) 3872-3876 [CrossRef] [PubMed].
  14. Grimm L.M., Goldoft M., Kobayashi J., Lewis J.H., Alfi D., Perdichizzi A.M., Tarr P.I., Ongerth J.E., Moseley S.L., Samadpour M., Molecular epidemiology of a fast-food restaurant-associated outbreak of Escherichia coli O157/H7 in Washington state, J. Clin. Microbiol. 33 (1995) 2155-2158 [PubMed].
  15. Gross W.G., Diseases due to Escherichia coli in poultry, in: Gyles C.L. (Ed.), Escherichia coli in domestic animals and humans, CAB International, Wallingford, UK, 1994, pp. 237-259.
  16. Harder K.J., Nikaido H., Matsuhashi M., Mutants of Escherichia coli that are resistant to certain $\beta$-lactam compounds lack the ompF porin, Antimicrob. Agents Chemother. 20 (1981) 549-552 [PubMed].
  17. Heisig P., Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli, Antimicrob. Agents Chemother. 40 (1996) 879-885 [PubMed].
  18. Hooper D.C., Mechanisms of quinolone resistance, Drug Res. Updates 2 (1999) 38-55.
  19. Hooper D.C., Wolfson J.S., Quinolone antibacterial agents, 2nd ed., American society for microbiology, Washington, DC, 1993.
  20. Jellen-Ritter A.S., Kern W.V., Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with IS element transposition in Escherichia coli mutants selected with a fluoroquinolone, Abstract C437, 40th Interscience Conference on Antimicrob. Agents Chemother., Toronto, Canada, 2000.
  21. Levine M.M., Escherichia coli that cause diarrhoea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohaemorrhagic and enteroadherent, J. Infect. Dis. 155 (1987) 377-389 [PubMed].
  22. Ma D., Cook D.N., Alberti M., Pon N.G., Nikaido H., Hearst J.E., Molecular cloning and characterization of acrA and acrE genes of Escherichia coli, J. Bacteriol. 175 (1993) 6299-6313 [PubMed].
  23. Ma D., Cook D.N., Hearst J.E., Nikaido H., Efflux pumps and drug resistance in Gram-Negative bacteria, Trends Microbiol. 2 (1994) 489-493 [CrossRef] [PubMed].
  24. Ma D., Cook D.N., Alberti M., Pon N.G., Nikaido H., Hearst J.E., Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli, Mol. Microbiol. 16 (1995) 45-55 [PubMed].
  25. Martinez-Martinez L., Pascual A., Jacoby G.A., Quinolone resistance from a transferable plasmid, Lancet 351 (1998) 797-799 [CrossRef] [PubMed].
  26. Mazzariol A., Tokue Y., Kanegawa T.M., Cornaglia G., Nikaido H., High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA, Antimicrob. Agents Chemother. 44 (2000) 3441-3443 [CrossRef] [PubMed].
  27. Mortimer P.G., Piddock L.J.V., The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli, J. Antimicrob. Chemother. 32 (1993) 195-213 [CrossRef].
  28. Nikaido H., Outer membrane barrier as a mechanism of antimicrobial resistance, Antimicrob. Agents Chemother. 33 (1989) 1831-1836 [PubMed].
  29. Nikaido H., Prevention of drug access to bacterial targets: permeability barriers and active efflux, Science 264 (1994) 382-388 [CrossRef].
  30. Nikaido H., Antibiotic resistance caused by Gram-Negative multidrug efflux pumps, Clin. Infect. Dis. 27 (S1) (1998) 32-41.
  31. Nikaido H., Vaara M., Molecular basis of bacterial outer membrane permeability, Microbiol. Rev. 49 (1985) 1-32 [PubMed].
  32. Oethinger M., Kern W.V., Jellen-Ritter A.S., McMurry L.M., Levy S.B., Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump, Antimicrob. Agents Chemother. 44 (2000) 10-13 [PubMed].
  33. Okusu H., Ma D., Nikaido H., AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants, J. Bacteriol. 178 (1996) 306-308 [PubMed].
  34. Peng H., Marians K.J., Escherichia coli topoisomerase IV. Purification, characterization, subunit structure and subunit interactions, J. Biol. Chem. 268 (1993) 24481-24490 [PubMed].
  35. Piddock L.J., Mechanisms of resistance to fluoroquinolones: state of the art 1992-1994, Drugs 49 (S2) (1995) 29-35.
  36. Piddock L.J., Fluoroquinolone resistance, BMJ 317 (1998) 1029-1030 [PubMed].
  37. Poole K., Efflux-mediated resistance to fluoroquinolones in Gram-Negative bacteria, Antimicrob. Agents Chemother. 44 (2000) 2233-2241 [CrossRef] [PubMed].
  38. Reece R.J., Maxwell A., DNA gyrase: structure and function, Crit. Rev. Biochem. Mol. Biol. 26 (1991) 335-375 [PubMed].
  39. Webber M.A., Piddock L.J.V., Expression of marA, soxS and acrB in fluoroquinolone-resistant clinical isolates of E. coli, Abstract C759, 40th Interscience Conference on Antimicrob. Agents Chemother, Toronto, Canada, 2000.
  40. White D.G., Piddock L.J.V., Maurer J.J., Zhao S., Ricci V., Thayer S., Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli, Antimicrob. Agents Chemother. 44 (2000) 2897-2899 [CrossRef] [PubMed].
  41. Yoshida H., Bogaki M., Nakamura M., Nakamura S., Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli, Antimicrob. Agents Chemother. 34 (1990) 1271-1272 [PubMed].
  42. Yoshida H., Bogaki M., Nakamura M., Yamanaka L.M., Nakamura S., Quinolone resistance determining region in the DNA gyrase gyrB gene of Escherichia coli, Antimicrob. Agents Chemother. 35 (1991) 1647-1650 [PubMed].